INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/30/2026
Back to search
Official data from USPTO
SURGVISION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
07/30/2026
Trademark type
Combined
Nice classes
5, 10, 44
Filing date
02/07/2017
Registration date
10/02/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/18/2025
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
DE
Examiner
RADEMACHER, APRIL LUEDERS
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "SURGVISION", where "SURG" appears in light blue and "VISION" appears in dark blue. A shape resembling a magnifying glass appears to the right of the wording. The magnifying glass is light blue with a dark blue circle in the center.
Holders and representatives
Holders
SurgVision GmbH
SurgVision B.V.
Representatives
Michael M. Morris Woodard Emhardt Moriarty McNett & Henry
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes; contrast agents for medical imaging; contrast agents for use with medical equipment
Class 10
Diagnosticexamination and monitoring devices and instrumentsnamely diagnostic apparatus for the visualisation of fluorescence in cancer; medical testing equipment for visualisation of cancer tissue and cells; optical instruments for medical purposesnamely fluorescense instruments for locating fluorescent tracers in tissue
Class 44
Medical services; medical screening; medical analysisnamely for the visualisation of fluorescence in cancer tissue; medical imaging; medical diagnostic servicesnamely medical testing for diagnostic or treatment purposes in the field of oncology; medical treatments of various cancer indicationsbreast cancerperitoneal cancerlung cancer and other cancer indications where fluorescent agents are used in cancer surgery
Publications
History of USPTO decisions and trademark events.
47 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/10/2026
INPC
INVALIDATION PROCESSED
07/10/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
12/18/2025
C71T
CANCELLED SECTION 71
04/18/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/02/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/13/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/01/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/16/2019
FIMP
FINAL DISPOSITION PROCESSED
01/16/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/02/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/29/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
10/02/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/17/2018
PUBO
PUBLISHED FOR OPPOSITION
07/17/2018
GPNX
NOTIFICATION PROCESSED BY IB
07/14/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/27/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/27/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/27/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/11/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/11/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/11/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/11/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/11/2018
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/11/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/05/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/20/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/20/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/05/2018
GNFR
FINAL REFUSAL E-MAILED
01/05/2018
CNFR
FINAL REFUSAL WRITTEN
01/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/05/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2017
RFNT
REFUSAL PROCESSED BY IB
06/24/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2017
RFRR
REFUSAL PROCESSED BY MPU
06/06/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/24/2017
CNRT
NON-FINAL ACTION WRITTEN
05/23/2017
MAFR
APPLICATION FILING RECEIPT MAILED
05/19/2017
DOCK
ASSIGNED TO EXAMINER
05/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/15/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/11/2017
Continuous trademark protection
Get notified about every new filing that threatens SURGVISION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.